The future is fandom. And Chorus is redefining the artist-fan connection. Launched in 2022, Chorus is an artist founded and led music technology platform that directly connects artists with their super fans. Chorus has designed a pathway for artists to leverage their existing communities and artistic content to create a new and direct revenue vertical. Artist ownership is core to Chorus’ mission, giving artists control of their financial destinies and fan data while maintaining their own unique artistic vision.Learn more at thechorus.com

Ceribell, Inc., the developer of the first AI-powered point-of-care EEG diagnostic system, is revolutionizing seizure management in acute care. Ceribell's mission is to make EEG diagnostics widely available, more efficient, and more cost-effective, to improve the detection and treatment of neurological conditions. The Ceribell system provides rapid access to accurate diagnostic information and continuous monitoring at the bedside 24/7, enabling precise patient care and hospital-wide efficiencies. The Ceribell system first received FDA 510(k) clearance in 2017 and is commercially available in the United States. The latest ClarityPro™ AI algorithm is the first and only FDA-indicated software for the diagnosis of electrographic status epilepticus with CMS approved New Technology Add-on Payment (NTAP).

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel, small molecule therapies for patients in need of new treatments across many complicated diseases. Using Symphony™, a proprietary AI platform, Aria has redefined the drug discovery approach, increasing success rates by mitigating risks throughout the drug development process. Aria has shown promise across a diverse range of therapeutic areas with the ability to address over 1,000 diseases, with lead programs in lupus, CKD, IPF, and NASH.

BioQ designs ready-to-use systems for hard-to-prepare and hard-to-administer infusible drugs – thereby simplifying the infusion process from beginning to end. invenious™ infusion systems are designed uniquely to each drug’s preparation and dosing requirements. BioQ's pipeline includes non-opioid post-surgical pain management, anesthesia & sedation, oncology, and antibiotics.